0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

THERAPY WITH SULFONAMIDE COMPOUNDS FOR PATIENTS WITH DAMAGE TO THE LIVER

OSLER L. PETERSON, M.D.; EMMANUEL DEUTSCH, M.D.; MAXWELL FINLAND, M.D.
Arch Intern Med (Chic). 1943;72(5):594-612. doi:10.1001/archinte.1943.00210110031003.
Text Size: A A A
Published online

The presence of damage to the liver is one of the few conditions which are still considered to contraindicate the use of sulfonamide compounds or, at least, to require caution in their administration. Many clinical reports, however, include cases in which these drugs have been successfully used for the treatment of infections in the presence of jaundice of varying intensity and for patients with extensive damage to the liver. Adequate studies of the effects of this form of therapy on the hepatic function in such cases are few. In this paper there is reported a series of 37 patients who presented evidence of acute or chronic damage to the liver and who, for various reasons, received either sulfathiazole or sulfadiazine in full therapeutic doses. In each of their cases some studies were made in an attempt to determine the effect of the sulfonamide therapy on hepatic function.

LITERATURE  The liver

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();